Ontology highlight
ABSTRACT:
INSTRUMENT(S): LTQ Orbitrap Velos, Q Exactive
ORGANISM(S): Homo Sapiens (human)
TISSUE(S): Cell Culture, Early Embryonic Cell
DISEASE(S): Fanconi Anemia Complementation Group A
SUBMITTER: Nicholas Woods
LAB HEAD: Nicholas T. Woods, Ph.D.
PROVIDER: PXD010570 | Pride | 2019-07-25
REPOSITORIES: Pride
Action | DRS | |||
---|---|---|---|---|
20161109_NW_S1.raw | Raw | |||
20161109_NW_S2.raw | Raw | |||
20161109_NW_S3.raw | Raw | |||
20161109_NW_S4.raw | Raw | |||
20161109_NW_S5.raw | Raw |
Items per page: 5 1 - 5 of 42 |
Lagundžin Dragana D Hu Wen-Feng WF Law Henry C H HCH Krieger Kimiko L KL Qiao Fangfang F Clement Emalie J EJ Drincic Andjela T AT Nedić Olgica O Naldrett Michael J MJ Alvarez Sophie S Woods Nicholas T NT
PloS one 20190828 8
Hyperinsulinemia affects 72% of Fanconi anemia (FA) patients and an additional 25% experience lowered glucose tolerance or frank diabetes. The underlying molecular mechanisms contributing to the dysfunction of FA pancreas β cells is unknown. Therefore, we sought to evaluate the functional role of FANCA, the most commonly mutated gene in FA, in glucose-stimulated insulin secretion (GSIS). This study reveals that FANCA or FANCB knockdown impairs GSIS in human pancreas β cell line EndoC-βH3. To ide ...[more]